International Archives of

Cardiovascular DiseasesISSN: 2643-3966


 Open Access DOI:10.23937/2643-3966/1710060

Long-Term Follow-Up of Patients with Brugada Syndrome: Foremost Risk Factors Associated with Arrhythmic Events

Volkan Camkiran, MD, Ozge Ozden, MD and Ilyas Atar

Article Type: Original Article | First Published: 2023/10/30

Brugada syndrome (BS) is characterized by ST segment elevation in right precordial leads (V1-3), ventricular tachycardia (VT), ventricular fibrillation (VF) and sudden cardiac death (SCD) in individuals without structural heart disease. The aim of this study was to assess parameters associated with in patients with BS....

 Open Access DOI:10.23937/2643-3966/1710059

Medical and Day-to-Day Burden on Families of Children with Hypoplastic Left Heart Syndrome Who Have Undergone Single Ventricle Surgical Palliation over a Decade

Erin Hanft, Elena Abascal, Anne Ferris and Elvira Parravicini

Article Type: Original Article | First Published: 2023/10/22

Children with hypoplastic left heart syndrome (HLHS) and their families face unique medical and non-medical challenges throughout their entire life. The objective of this research is to describe day-to-day burden on families and medical outcomes of children with (HLHS) who underwent surgical palliation....

 Open Access DOI:10.23937/2643-3966/1710058

Complications of a Giant Left Atrium - Extensive Thrombus Formation Despite Therapeutic Anticoagulation

Charles Croughan, MD, Balaj Rai, MD, Zachary Gilbert, MD, William David Nickell PA-C, Nathaniel Dittoe, MD, Brian Schwartz, MD and Peter Pavlina, MD

Article Type: Case Report | First Published: 2023/09/11

Left atrial thrombus (LAT) formation is a feared complication of atrial fibrillation, as it can lead to thromboembolic stroke or thromboembolism to another peripheral region causing ischemia. Despite therapeutic anticoagulation, recurrence of thrombi is still possible, although unlikely. Prevention strategies may include reducing left atrial size along with treatment by surgical removal. We present a case of a patient with a large left atrial thrombus in the setting of previous mitral valve sten...

 Open Access DOI:10.23937/2643-3966/1710057

Hypertrophic Cardiomyopathy? Think Again, PRKAG2 Syndrome

Juan Linares, MD, Charles Croughan, MD, Damian Valencia, MD, Rehan Ahmed, MD and Vaskar Mukerji, MD

Article Type: Case Report | First Published: 2023/09/10

Hypertrophic cardiomyopathy (HCM) is a disorder characterized by ventricular hypertrophy and myocyte disarray that increases the risk of arrhythmic sudden cardiac death. HCM phenocopies are disease entities sharing a left ventricular hypertrophy phenotype but arising from a different pathologic mechanism. Patients with PRKAG2 syndrome (PS), a glycogen storage disease, are often misdiagnosed as having HCM. Clinicians must be familiar with red flags alerting to the possibility of this important di...

 Open Access DOI:10.23937/2643-3966/1710055

Emergent TAV-in-TAV Following Acute Hemolytic Anemia Secondary to Undersized Transcatheter Heart Valve Prosthesis

Agata Sularz, MB BChir MA(Cantab.), Hashrul Rashid, MBBS(Hons), PhD, Jane Hancock, MB ChBPhD, Nikolaos Papamichael, MD, PhD, Bernard Prendergast, BMBS, DM, Simon Redwood, MBBS, MD and Tiffany Patterson, MBBS, BSc, PhD

Article Type: Case Report | First Published: 2023/05/13

Paravalvular leak (PVL) driven intravascular hemolysis (IVH) is a recognized complication of surgical aortic valve replacement. This has been described less following transcatheter aortic valve implantation (TAV). We present a case of a patient with severe life-threatening hemolytic anemia following TAV, requiring multiple blood transfusions, and emergent TAV-in-TAV procedure....

 Open Access DOI:10.23937/2643-3966/1710054

Cardiovascular Disease as a Chronic Sequel to COVID-19: A Case Report

Oscar Rene Vazquez Melo, Ramon Eduardo Garcia Cahuich, Jose Julián Sosa Rodriguez and María Valeria Jiménez Báez

Article Type: Case Report | First Published: January 26, 2023

COVID-19 infection has shown cardiovascular involvement, particularly when it has a moderate to severe presentation. This alteration has been manifested in arrhythmias, myocarditis, and acute myocardial infarction, among others; persistence of these cardiovascular alterations in the short and medium term has been documented. In Latin America there are no reports of long-term cardiovascular sequelae. We present the case of a 46-year-old female with no previous history of cardiovascular disease wh...

Volume 7
Issue 1